Business
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
MISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ...
About this update from Microbix Biosystems Inc.
[{"type":"text","content":"Microbix & Seegene Mexico Collaborate to Improve Test AccuracyMaking HPV Tests & Quality Assessment Products Available across Mexico\n\n\n\n MISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (\n \n TSX: MBX, OTCQX: MBXBF, Microbix®\n \n ), a life sciences innovator, manufacturer, and exporter, and Seegene Mexico S.A.P.I. de C.V. (\n \n Seegene Mexico\n \n ), a firm focused upon transforming molecular diagnostics with innovative multiplex solutions, announce that Microbix external third-party quality assessment products (\n \n QAPs®\n \n ) will be used to support the clinical use of the Allplex™ and Anyplex™ molecular multiplex assays of Seegene Mexico for detecting infection with high-risk types of the human papilloma virus (\n \n HPV\n \n ).\n \n\n HPV is a family of approximately 100 related viruses, and most people will be infected with one or more types over their lifetime. Infections with lower-risk types of HPV can lead to warts, while chronic infection with high-risk types of HPV can cause cancers, most notably cervical cancer. Molecular assays to detect infection with HPV provide important preventative health information years in advance of pathology-based methods such as the “Pap Test.” However, molecular tests require rigorous and ongoing quality management systems (including QAPs) to ensure the integrity of their workflows and resulting accuracy.\n \n\n Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify 19 higher-risk and 9 lower-risk HPV genotypes. Using semi-quantitative data (\n \n i.e.\n \n , Ct values), the Allplex HPV 28 also provides information on infection status and genotype distribution. In turn, the HPV HR detection assays on the two systems enable the detection of each higher-risk HPV type.\n \n\n Seegene Mexico is the national affiliate of Seegene Inc., a multinational diagnostics company based in South Korea that is a leader in the development and commercialization of multiplex PCR molecular tests. Seegene and its affiliates are deeply engaged with improving screening for HPV infection and resulting cervical cancers across Mexico, throughout Central and South America, and globally.\n \n\n Use of HPV-focused QAPs will help ensure training and...